Akoya Biosciences, Inc. (AKYA)

Akoya Biosciences Revenue

Akoya Biosciences had revenue of $16.64M in the quarter ending March 31, 2025, a decrease of -9.32%. This brings the company's total for the last twelve months to $79.96M, down -14.55% year-over-year. In the year 2024, Akoya Biosciences had annual revenue of $81.67M, down -15.48%.

• Revenue (ttm): $79.96M
• Revenue Growth: -14.55%
• P/S Ratio: 0.80
• Revenue / Employee: $390,054
• Employees: 205
• Market Cap: 64.34M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

• Instruments 42.10M 43.6%
• Service and Other 29.22M 30.2%
• Consumables 24.13M 25.0%
• Standalone Software 1.18M 1.2%

By Geography

• North America 58.28M 60.3%
• EMEA 21.80M 22.6%
• APAC 16.55M 17.1%

Fiscal year ended Dec 31, 2023 See the full Akoya Biosciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	81.67M	-14.96M	-15.48%
Dec 31, 2023	96.63M	21.77M	29.09%
Dec 31, 2022	74.86M	19.94M	36.31%
Dec 31, 2021	54.92M	12.47M	29.39%
Dec 31, 2020	42.44M	207.00K	0.49%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error